Progress in Elucidating Potential Markers and Mechanisms of Rapid Protection Conferred by the VSV-Vectored Ebola Virus Vaccine
ABSTRACT Research progress over the past 20 years has yielded several experimental Ebola virus (EBOV) vaccine candidates, which were shown to be effective in nonhuman primates when given 28 days before a lethal challenge. Of these, the vesicular stomatitis virus (VSV)-vectored vaccine against EBOV (...
Guardado en:
Autor principal: | Gary Wong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc4d4dfa7ac14fefb4b974a9957f2471 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Andrea R. Menicucci, et al.
Publicado: (2019) -
Ebola virus disease: Essential clinical knowledge
por: Mahmoud Tawfik Khalafallah, et al.
Publicado: (2017) -
Ébola: caracterización, historia y manifestaciones cutáneas; lo que debemos saber
por: Kolbach,Marianne, et al.
Publicado: (2015) -
Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors
por: Megan M. Slough, et al.
Publicado: (2019) -
Modeling Ebola Virus Transmission Using Ferrets
por: Marc-Antoine de La Vega, et al.
Publicado: (2018)